Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: FTSE (0.3%), DAX (0.4%), CAC (0.5%), IBEX (0.4%), MIB (0.2%)

Jun 11 ,2026

  • Synopsis

    • European equity markets set to open broadly in the red. Asian equities trading lower Thursday. Tech under scrutiny with Taiwan leading declines though Japan and South Korea off worst levels. Greater China benchmarks accumulating losses. S&P 500 futures reversing higher afterhours. ORCL was down sharply in US after hours after its earnings report.

    • Crude up further on renewed Middle East hostilities but below earlier highs. US launched another wave of strikes against Iran, targeting air defense systems, radars and drone command and control units. Crude gave back some of its earlier gains after CENTCOM declared mission complete. Trump had flagged an end to bombing after claiming Iran asked him to stop while warning strikes will restart unless Iran signs agreement. Unclear how flareup in hostilities will influence negotiations after Trump accused Tehran of stringing US along. Press sources have described Iran less willing to engage following recent clashes while nuclear program and frozen assets remain sticking points.

    • European macro data releases include Sweden May final CPI, Ireland May CPI, Belgium Apr industrial production

    • UK RICS House Price Balance on the tape (Link). The UK residential market remained challenging in May, though some small signs of stabilisation are emerging. New buyer enquiries held at a net balance of -34%, unchanged from April - the first month since January without further deterioration. Agreed sales were similarly flat at -37%. However, time to completion rose to 21.5 weeks, the longest since records began in 2017. House prices continued to edge lower, with the net balance steady at -35% for a second consecutive month. Price weakness was most pronounced in the South East and East Anglia, while Northern Ireland continued to see growth.

    • In central banks, ECB interest rate decision at 14:15CET, press conf at 14:45 with the latest Staff macroeconomic projections also due to be released at 15:45. Benchmark interest rate is expected to be increased by +25bps to 2.25%. Other interest rate decisions include Russia central bank at 12noon CET with press conf and Turkey central bank at 13:00CET with no changes expected to benchmark rates in Turkey 37.0% and Russia 5.75%. Norges Bank publishes its Regional Network: Report 2/2026 at 10:00CET whilst ECB media seminar (through Fri) speakers include ECB's Montagner at 10:00CET and Lane at 17:00. ECB's Donnery speech at 10:00BST at Central Banking Meetings (Wed-Thu) 'Strategic Turning Points: Markets, Independence and Automation'. European Stability Mechanism's board of governors holds its annual meeting.

    • In politics, Chancellor Merz statement in the Bundestag at 9:00CET on the upcoming EU summit and also attends/delivers speech at Family Business Day, which is attended by other ministers. In Denmark there's Folkemødet (through Sat) with Denmark central bank's Krogstrup panellist at 10:15CET title AI: Increased productivity or shock to the economy?.

    • OPEC monthly oil market report is due to be released and EU's Dombrovskis and ECB's Cipollone among the participants at Eurogroup meeting takes place. EU's von der Leyen to meet with Norway's PM Støre at 11:00CET. Fitch Rating webinar at 15:00BST Building Materials Market Outlook and Capital Allocation. Moody's France Public Sector Rendez-vous 2026 is discussions focused on economic outlook, systemic risks, and government priorities from 17:30CET, speakers include former minister of the economy and finance Bruno Le Maire at 17:45. InstallatörGruppen (IG.DC) first day of trading on Nasdaq Copenhagen.

    • On the corporate front, Hugo Boss (BOSS.GR) noted that Frasers Group (FRAS.LN) has published its intention to launch a voluntary public takeover offer to the company's shareholders to acquire all of its shares. This takeover offer has not been coordinated with the company. The indicated offer price of €38.00 for each of the company's shares represents a premium of 4% to the company's last closing share price of €36.46.

  • Politics/Macro/World News

    • US launches fresh strikes against Iran, Trump warns bombing will restart unless Tehran signs deal:

    • China Cancels High-level Meetings With EU (FT )

    • Europeans to Seek Trump Buy-In at G7 for Peace Talks With Russia (Bloomberg)

    • UK RICS House Price Balance May (35%) vs consensus (32%)

  • Top company news

    • Earnings/updates

      • CAMX.SS (Camurus) -- provides regulatory update on US NDA for CAM2029 (Oclaiz) in acromegaly

      • FHZN.SW (Flughafen Zuerich) -- reports May traffic statistics

      • VVY.NA (Vivoryon Therapeutics) -- reports Q1 net income (€1.8M) vs year-ago (€2.5M); provides business update

      • Also reporting today

        • Earnings:

          • DACHs: AT & S Austria Technologie & Systemtechnik (ATS.AV)

          • Nordics: Roblon (RBLN.B.DC)

          • UK: Halma (HLMA.LN), Safestore Holdings (SAFE.LN), Wizz Air Holdings (WIZZ.LN), NCC Group (NCC.LN), RWS Holdings (RWS.LN), PayPoint (PAY.LN), Norcros (NXR.LN)

        • Trading Update:

          • Nordics: Puuilo (PUUILO.FH)

          • Other: Origin Enterprises (OIZ.ID)

        • Traffic: DFDS (DFDS.DC), Heathrow Airport Holdings (+HTR.LN), Aeroflot-Russian Airlines (AFLT.RU)

        • CMD/Events: Grafton Group (GFRU.LN), hVIVO (HVO.LN)

    • M&A

      • TNXT.IM (Tinexta) -- Zinc BidCo (Advent and Nextalia) files offer document with CONSOB in connection with offer for remaining Tinexta shares (post EU close 10-Jun)

      • BOSS.GR (Hugo Boss) -- holder Frasers Group plc offers shareholders a voluntary public takeover offer to acquire all no-par value registered shares

      • BOSS.GR (Hugo Boss) -- informs about unsolicited voluntary takeover offer by Frasers group

      • KTN.GR (Kontron) -- Ennoconn to launch mandatory takeover offer to Kontron AG shareholders

      • KIN.BB (Kinepolis Group) -- Kinepolis (Euronext: KIN) has reached an agreement with Harbor Lights Entertainment (formerly National Amusements Inc.) to acquire Showcase Cinemas in the US

      • IMPN.SW (Implenia) -- acquires structural engineering specialist Zigmo Engineering in Germany; terms undisclosed

      • EQT, Blackstone and Bain firms showing interest in medical technology distributor Device Technologies - The Australian

    • Healthcare

      • NOVN.SW (Novartis) -- announces that biomarker cohort of the FORTITUDE Phase I/II study of del-brax met its primary and key secondary endpoints

      • ROP.SW (Roche Holding) -- Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies

      • ROP.SW (Roche Holding) -- FDA grants Priority Review for Roche's Tecentriq for certain type of stage III colon cancer

      • GMAB.DC (Genmab) -- NICE recommends Genmab's Tivdak to treat recurrent or metastatic cervical cancer that has progressed on or after systemic treatment

      • NYXH.BB (Nyxoah) -- announces $110M in aggregate financings to accelerate Genio's U.S. commercial launch

      • POXEL.FP (Poxel) -- appoints Yves Decadt as CEO, effective 10-Jun-26

      • OSE.FP (OSE Immunotherapeutics) -- Transcript Intelligence: OSE Immunotherapeutics Analyst Meeting - Key Opinion Leader

    • Other

      • AIR.FP (Airbus SE) -- awarded contract for Copernicus Sentinel-1 NG radar instruments at ILA Berlin

      • TIT.IM (Telecom Italia) -- to proceed with 1-for-10 reverse stock split on 15-Jun

      • DG.FP (VINCI SA) -- signs share purchase agreement with investment services provider as part of buyback program

      • SPM.IM (Saipem) -- awarded a new onshore contract in Saudi Arabia

      • DKSH.SW (DKSH Holding) -- enters strategic distribution partnership with BridgeBio to support regulatory evaluation and potential patient access to a Transthyretin Stabilizer for ATTR-CM in Australia, Singapore, South Korea, and Taiwan

      • TGS.NO (TGS-NOPEC Geophysical Co.) -- has been awarded a streamer acquisition contract in the Africa & Middle East region

  • Key rating changes

    • Upgrades

      • VOLV.B.SS (Volvo) -- to buy from hold at Pareto

      • P911.GR (Porsche) -- to buy from neutral at Goldman Sachs

    • Downgrades

      • VOD.LN (Vodafone Group) -- to equal weight from overweight at Barclays

      • SCMN.SW (Swisscom) -- to underweight from overweight at Morgan Stanley

      • NHY.NO (Norsk Hydro) -- to hold from buy at Pareto

  • Data

    • Nikkei +0.04% to 64202.65

    • Hang Seng (0.98%) to 24169.62

    • Shanghai Composite (0.34%) to 3979.57

    • S&P futures +28.0 vs prior close of 7278.5

    • €-$ +0.0010 or +0.09% to 1.1548

    • $-¥ (0.01) or (0.01%) to 160.55

    • €-¥ +0.16 or +0.09% to 185.38

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.